Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisPierre D. Delmas, Steven Boonen, Z. Man et al.|Bone|2007Cited by 97
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tabletMichael R. McClung, Robert R. Recker, Paul D. Miller et al.|Osteoporosis International|2011Cited by 46
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year dataMichael R. McClung, P. D. Delmas, S. Boonen et al.|Osteoporosis International|2012Cited by 31